Morgan Stanley Knock-Out PGR/ DE000MA5QB87 /
| 15/05/2024 17:34:01 | Chg.-0.37 | Bid20:29:37 | Ask20:29:37 | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 10.05EUR | -3.55% | 9.90 Bid Size: 15,000 |
9.92 Ask Size: 15,000 |
Progressive Corporat... | 101.1014 - | 31/12/2078 | Call |
GlobeNewswire
19:30
Private Equity Firm, Initium Management, Launched by Tested Team of Trusted Operators
GlobeNewswire
14:40
Thurgood Marshall College Fund added Denmark Technical College to its membership
GlobeNewswire
14/05
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment...
GlobeNewswire
13/05
Avalyn Announces Multiple Presentations on its Lead Program, AP01, for Pulmonary Fibrosis and its Ap...
GlobeNewswire
13/05
BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transt...
GlobeNewswire
13/05
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...
GlobeNewswire
09/05
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st ...
GlobeNewswire
09/05
Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate...
GlobeNewswire
08/05
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Plan...
GlobeNewswire
07/05
MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-1...
GlobeNewswire
06/05
Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...
GlobeNewswire
04/05
The National Fire Sprinkler Association's Class of 2024: Honoring Fire Sprinkler Industry Greats
GlobeNewswire
02/05
PyroGenesis Announces 28-Day Lab Strength Tests Achieve Up to 99.56% Above Compressive Strength Targ...
GlobeNewswire
01/05
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...
GlobeNewswire
01/05
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 ...
GlobeNewswire
01/05
Atsena Therapeutics Announces Positive Clinical Data from the First Cohort of Phase I/II Trial Evalu...
GlobeNewswire
01/05
TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
25/04
Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Re...
